Skip to Content

EC 35 (Atelvia risedronate sodium delayed-release 35 mg)

Generic Name: risedronate

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Atelvia risedronate sodium delayed-release 35 mg. It is supplied by Allergan, Inc..

Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EC 35

Atelvia risedronate sodium delayed-release 35 mg EC 35

Atelvia

Generic Name
risedronate
Imprint
EC 35
Strength
risedronate sodium delayed-release 35 mg
Color
Yellow
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Allergan, Inc.
Inactive Ingredients
edetate disodium, ferric oxide yellow, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, microcrystalline cellulose, silicon dioxide, sodium starch glycolate type A potato, stearic acid, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00430-0979 Warner Chilcott
00591-3876 Watson Pharmaceuticals, Inc.

Get help with Imprint Code FAQs.

Related Images for "EC 35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.